Market News

2026-11-06. The following slide deck was published by Braveheart Bio, Inc.

While rival chipmakers bounce back from the midterm-driven selloff, Broadcom sits frozen despite triple-digit AI growth and a bargain multiple. What d...

Joby's FAA certification is entering its final stretch, a defense deal is on deck, and billions sit in the bank. So why does a mounting share count ha...

Blowout revenue couldn't stop the slide, and a Texas threat barely touches its leased campuses. So why does Applied Digital keep sinking with the pack...

A $25 billion buyback sparked a rally in Lam Research after a brutal chip selloff. But your semiconductor, tech, and Nasdaq-100 funds may hold the sam...

Freedom Broker analyst Saken Ismailov maintains MNTN (NYSE:MNTN) with a Buy and lowers the price target from $16.5 to $9.

2026-11-06. The following slide deck was published by MDA Space Ltd.

Aptiv has considerably underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Today's US market movers: SDA led gainers at 149.0%, while AIRS led losers at a 59.62% decline; see top gainers and losers with session moves.

Scott Melker discusses how Samsung Wallet (005930.KS) launched a new Stablecoin Account for eligible Galaxy users in the US. "The Daily Wolf with Scot...

IBM (NYSE: IBM), the University of Chicago, the State of Illinois, and Illinois Quantum and Microelectronics Park (IQMP) today unveiled an IBM Quantum...

Wrap Technologies, Inc. has appointed former New York City Police Department Deputy Commissioner Edward Delatorre Jr. to its Board of Directors, effec...

VANCOUVER, British Columbia & GRAPEVINE, Texas, November 06, 2026--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopha...

Airbnb (ABNB) is poised to sustain "healthy" growth into next year, aided by pricing initiatives and

Atlassian's (TEAM) strong execution in fiscal Q1 was offset by cautious guidance that increases inve

Freedom Broker analyst Ilya Zubkov maintains Niagen Bioscience (NASDAQ:NAGE) with a Buy and lowers the price target from $8.5 to $6.

By Karen Roman Reformation Inc. (NYSE: REF) said third quarter net revenue increased 19.1% to $173.6 million compared to the year prior thanks to stre...

Freedom Broker analyst Ilya Zubkov downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and raises the price target from $450 to $470.

AMC Entertainment CEO Adam Aron declared the company has finally recovered, posting record revenue and adjusted EBITDA for a second straight quarter.